Chronic Condition Management

Devices could help patients reduce or stop using tobacco, researchers say.

Researchers just now starting to get an idea of who is more likely to suffer from long COVID

Exponential rise in death rate is historic, even as adolescent drug use is low.

Genomic sequencing can identify genetic variants that may eventually lead to diseases or increase an individual’s risk of developing a specific disease.

Evidence suggests a second booster improve protection against severe COVID

Insurance a factor in access to drug treatments, a new study said.

Four new codes have been put in place in 2022.

Physicians have a role in stamping out weight bias.

Could be new challenge for Social Security, analyst says

May stop cycle of inflammation that can lead to diabetes and depression

Over-medicating may lead to adverse drug interactions and make their dementia worse

How to overcome the rising costs of obesity

Pending FDA approval, could be available in 2024.

Rural areas lag well behind their urban counterparts when it comes to COVID-19 vaccinations

The results are published online in Clinical Infectious Diseases.

The CDC is seeking comment on the voluntary guidelines, which come on the heels of the controversial 2016 guidance that placed hard caps on prescribing.

Big pharma and investors focusing on other segments despite the need for new therapeutics

These drugs treat everything from cancer to cognitive decline.

Apretude is approved for use in at-risk adults and adolescent to reduce the risk of sexually acquired HIV.

Blood clot risk in J&J higher for women, draws CDC concerns

Sanjay Rajagopalan, MD, the Herman K. Hellerstein, MD, chair in cardiovascular research at University Hospitals of Cleveland Harrington Heart & Vascular Institute, discusses the link between cardiovascular disease and air pollution and how primary care doctors can help patients lower their risk of cardiovascular disease caused by air pollution.

Identifying and assisting patients with social determinants is challenging, but can boost outcomes

Women and those in their 50s and early 60s reported the most stress about COVID

PreHevbrio is the only 3-antigen vaccine for Hepatitis B approved for adults